Sequential signaling cascade of IL-6 and PGC-1α is involved in high glucose-induced podocyte loss and growth arrest

DI Kim, SH Park - Biochemical and biophysical research communications, 2013 - Elsevier
DI Kim, SH Park
Biochemical and biophysical research communications, 2013Elsevier
Podocyte loss, which is mediated by podocyte apoptosis, is implicated in the onset of
diabetic nephropathy. In this study, we investigated the involvement of interleukin (IL)-6 in
high glucose-induced apoptosis of rat podocytes. We also examined the pathophysiological
role of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α) in
this system. High glucose treatment induced not only podocyte apoptosis but also podocyte
growth arrest. High glucose treatment also increased IL-6 secretion and activated IL-6 …
Podocyte loss, which is mediated by podocyte apoptosis, is implicated in the onset of diabetic nephropathy. In this study, we investigated the involvement of interleukin (IL)-6 in high glucose-induced apoptosis of rat podocytes. We also examined the pathophysiological role of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α) in this system. High glucose treatment induced not only podocyte apoptosis but also podocyte growth arrest. High glucose treatment also increased IL-6 secretion and activated IL-6 signaling. The high glucose-induced podocyte apoptosis was blocked by IL-6 neutralizing antibody. IL-6 treatment or overexpression induced podocyte apoptosis and growth arrest, and IL-6 siRNA transfection blocked high glucose-induced podocyte apoptosis and growth arrest. Furthermore, high glucose or IL-6 treatment increased PGC-1α expression, and PGC-1α overexpression also induced podocyte apoptosis and growth arrest. PGC-1α siRNA transfection blocked high glucose-induced podocyte apoptosis and growth arrest. Collectively, these findings showed that high glucose promoted apoptosis and cell growth arrest in podocytes via IL-6 signaling. In addition, PGC-1α is involved in podocyte apoptosis and cell growth arrest. Therefore, blocking IL-6 and its downstream mediators such as IL6Rα, gp130 and PGC-1α may attenuate the progression of diabetic nephropathy.
Elsevier